Statistics

Total Visits

Views
MERIBEL study: Efficacy of eribulin in first line of taxane-resistant patients with HER2 negative metastatic breast cancer12

Select a period of time:

Number of views in the range

Views
MERIBEL study: Efficacy of eribulin in first line of taxane-resistant patients with HER2 negative metastatic breast cancer3

Views

Views
May 20242
June 20240
July 20240
August 20240
September 20240
October 20241
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
 

Top cities views

Views
Chicago1